MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 2 filers reported holding MIRAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $255,000 | -28.0% | 319,344 | 0.0% | 0.00% | – |
| Q2 2020 | $354,000 | +149.3% | 319,344 | 0.0% | 0.00% | – |
| Q1 2020 | $142,000 | -7.2% | 319,344 | 0.0% | 0.00% | – |
| Q4 2019 | $153,000 | -34.3% | 319,344 | 0.0% | 0.00% | – |
| Q3 2019 | $233,000 | -70.7% | 319,344 | -11.1% | 0.00% | – |
| Q2 2019 | $794,000 | -12.7% | 359,243 | +10.3% | 0.00% | – |
| Q1 2019 | $909,000 | -23.5% | 325,686 | -16.9% | 0.00% | – |
| Q4 2018 | $1,188,000 | -41.4% | 392,116 | +8.0% | 0.00% | – |
| Q3 2018 | $2,026,000 | -11.1% | 362,957 | +2.0% | 0.00% | – |
| Q2 2018 | $2,280,000 | -0.7% | 355,817 | +8.6% | 0.00% | – |
| Q1 2018 | $2,297,000 | -33.0% | 327,593 | -0.3% | 0.00% | -100.0% |
| Q4 2017 | $3,427,000 | +21.5% | 328,548 | +2.9% | 0.00% | 0.0% |
| Q3 2017 | $2,820,000 | – | 319,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,142,580 | $2,451,000 | 0.41% |
| Virtu Financial LLC | 112,200 | $87,000 | 0.02% |
| Seelaus Asset Management LLC | 17,175 | $13,000 | 0.01% |
| Aveo Capital Partners, LLC | 16,732 | $13,000 | 0.01% |
| Qube Research & Technologies Ltd | 366,710 | $284,000 | 0.00% |
| Banque Cantonale Vaudoise | 50,000 | $39,000 | 0.00% |
| GSA CAPITAL PARTNERS LLP | 19,327 | $15,000 | 0.00% |
| OneDigital Investment Advisors LLC | 11,029 | $9,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,898 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 72,929 | $56,000 | 0.00% |